Abstract:Pallam Gopichand, 1 Girija Agarwal, 2 Mailan Natarajan, 1 Jharna Mandal, 1 Surendran Deepanjali, 3 Sreejith Parameswaran, 4 LN Dorairajan 5 1 Department of Microbiology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India; 2 Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India; 3 Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India; 4 Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India; 5 Department of Urology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, India Background: Rising rates of resistance to antimicrobial drugs among Enterobacteriaceae limit the choice of therapeutic agents to treat urinary tract infections. In this context we assessed the in-vitro effect of fosfomycin against extended-spectrum beta-lactamases, AmpC beta-lactamases and carbapenemase-producing strains of Escherichia coli, Klebsiella pneumoniae, Enterobacter spp, and P seudomonas aeruginosa isolated from the patients with urinary tract infection (UTI) and also studied the effect of fosfomycin on their biofilm formation. Materials and methods: A total of 326 multidrug-resistant (MDR) isolates comprising of Escherichia coli, Klebsiella pneumoniae, Enterobacter spp, and P seudomonas aeruginosa from the urine samples of the patients with a diagnosis of UTI were included in the study. MIC 50 and MIC 90 were detected by agar dilution method and the capacity to form biofilm in the presence of fosfomycin by these MDR isolates was assessed by the tissue culture plate method. Results: The MIC50 for meropenem (0.5 μgm/mL) and nitrofurantoin (32 μgm/mL) was within the susceptible range only for E. coli . Fosfomycin was the only antibiotic that inhibited 100% E.coli , 70% Klebsiella spp, and 50% Pseudomonas spp and 40% Enterobacter spp which included the extended-spectrum beta-lactamases producers. It showed a similar effect on carbapenemase producers and AmpC producers. Fosfomycin disrupted biofilm in 67% (n=141) E.coli , 74% (n=50) Klebsiella spp, 88% (n=27) Pseudomonas spp and 36% (n=23) Enterobacter spp at 24 hrs of incubation with a concentration of 2 fold dilution lower than that of the MIC. Conclusion : Fosfomycin showed a good inhibitory effect on the biofilms produced by the MDR organisms studied here. Keywords: fosfomycin, MDR, UTI, MIC, biofilm

Antibiotic Resistance Patterns Among Uropathogens in Female Outpatients Affected by Uncomplicated Cystitis: Focus on Fosfomycin Trometamol

Prevalence of Fosfomycin Resistance Among Enterobacterales Isolates in A Tertiary Care Hospital from Turkey

Prevalence of Fosfomycin Resistance in Methicillin-Resistant Staphylococcus Aureus Isolated from Patients in a University Hospital in China from 2013 to 2015.

In Vitro Susceptibility of Escherichia Coli Strains Isolated from Urine Samples Obtained in Mainland China to Fosfomycin Trometamol and Other Antibiotics: a 9-Year Surveillance Study (2004–2012)

Antimicrobial Susceptibilities of Clinical Bacterial Isolates from Urinary Tract Infections to Fosfomycin and Comparator Antibiotics Determined by Agar Dilution Method and Automated Micro Broth Dilution

Update on Urinary Tract Infection Antibiotic Resistance—A Retrospective Study in Females in Conjunction with Clinical Data

In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens

The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study

Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin

Efficacy and Safety of Oral Fosfomycin Trometamol for the Treatment of Lower Urinary Tract Infections Caused by Multi Drug Resistant Bacteria：an Open-Label, Uncontrolled, Multicenter Study

Patterns of Antibiotic Resistance in Urinary Tract Infections: A Retrospective Observational Study

Emergence of Fosfomycin Resistance by Plasmid-Mediated fos Genes in Uropathogenic ESBL-Producing E. coli Isolates in Mexico

Emerging Resistance among Uropathogens: Is Fosfomycin Revival the Best Hope?

Prescription of antibiotics for urinary tract infections in outpatient care in Bavaria: An analysis of routine data

Bacteriological and molecular study of fosfomycin resistance in uropathogenic Escherichia coli

In vitro susceptibility to fosfomycin in clinical and environmental extended-spectrum beta-lactamase producing and/or ciprofloxacin-non-susceptible Escherichia coli isolates

Antibiotic Resistance Among Uropathogenic Escherichia coli

In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

Retrospective 8-Year Study on the Antibiotic Resistance of Uropathogens in Children Hospitalised for Urinary Tract Infection in the Emilia-Romagna Region, Italy

Efficacy and safety of fosfomycin trometamol for urinary tract infection: a Meta-analysis